Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
Background. Lipohypertrophy (LH) of subcutaneous tissue is an insulin-induced complication occurring in patients with diabetes. We aimed to define the prevalence of LH and identify its risk factors in type 1 diabetes (T1DM) patients treated with continuous subcutaneous insulin infusion (CSII). Mater...
Saved in:
| Main Authors: | Damian Ucieklak, Sandra Mrozinska, Aleksandra Wojnarska, Maciej T. Malecki, Tomasz Klupa, Bartłomiej Matejko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2022/9169296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Hidden Impact: Insulin Lipohypertrophy
by: Kristjana Mitrollari, et al.
Published: (2025-07-01) -
Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
by: Vadim V. Klimontov, et al.
Published: (2018-09-01) -
Efficacy of Sound Touch Elastography in Assessing Subcutaneous Lipohypertrophy from Insulin Injections
by: Xu J, et al.
Published: (2024-11-01) -
The Distinct Ultrasound Characteristics and Prognostic Features of Insulin-Induced Lipohypertrophy: A Systematic Review
by: Yang H, et al.
Published: (2025-03-01) -
Insulin-Related Skin Lipohypertrophy in Type Two Diabetes: A Clinical Study of a Case Series, with Ultrasonographic and Histopathologic Implications
by: Sandro Gentile, et al.
Published: (2024-12-01)